Total Funding
89
85
Total FundingPost-IPO Equity raised
Growth Score
1 pts
Heat Score
22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
91799
Pacific Edge is a Molecular cancer diagnostics company.
Thomas Nifong: VP Lab Operations and Medical DirectorPast Role: Metamark Genetics, Vice President of Clinical Operations
Julie Nerino: Chief Executive Officer
About the Company
Pacific Edge is a cancer diagnostics company. They specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Their products are built from their proprietary genetic databases, which are used to identify diagnostic
and prognostic biomarkers for cancer.
